Table 1 Patient demographics and clinical characteristics
Clinical Characteristics | All (n = 49) |
|---|---|
Age (Median = 62) | |
<65 | 33 (67.3%) |
≥ 65 | 16 (32.7%) |
Gender | |
Male | 34 (69.4%) |
Female | 15 (30.6%) |
Smoking status | |
Smoker | 23 (46.9%) |
Non-smoker | 26 (53.1%) |
Stage | |
III | 8 (16.3%) |
IV | 41 (83.7%) |
Metastasis | |
0 | 8 (16.3%) |
1 | 19 (38.8%) |
> 1 | 22 (44.9%) |
NSCLC subtype | |
Adenocarcinoma | 35 (71.4%) |
Squamous | 13 (26.5%) |
other | 1 (2.0%) |
Response | |
CR | 1 (2.0%) |
PR | 21 (42.9%) |
SD | 19 (38.8%) |
PD | 6 (12.2%) |
NA | 2 (4.1%) |
Therapy | |
Platinum-based chemotherapy | 13 (26.5%) |
Platinum-based chemotherapy/immunotherapy | 32 (63.3%) |